Ignite Creation Date:
2024-05-06 @ 8:12 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06284941
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-02-29
First Post:
2024-02-04
Brief Title:
A Study of Ropivacaine Complex Methylene Blue Fascia Iliaca Compartment Block on Analgesia in Patients Undergoing Hip Arthroplasty
Sponsor:
Wang wanxia
Organization:
Yangzhou University
Study Overview
Official Title:
A Study of Ropivacaine Complex Methylene Blue Fascia Iliaca Compartment Block on Analgesia in Patients Undergoing Hip Arthroplasty
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Total hip arthroplasty is currently the most effective method for treating hip joint lesions and improving quality of life but postoperative severe pain is not conducive to rapid recovery of patients In recent years the widespread application of ultrasound has achieved good clinical results in iliac fascia block for postoperative analgesia in THA However the use of high-dose local anesthetics can increase the risk of local anesthetic poisoning and the single block analgesia time is generally less than 24 hours Methylene blue as a long-acting analgesic drug can block the pain transmission of nerve fibers for a long time achieving analgesic effects without damaging neurons This study used ultrasound-guided ropivacaine combined with methylene blue to perform iliac fascia block on patients undergoing total hip replacement with the aim of prolonging pain relief time reducing complications and promoting postoperative recovery on the basis of traditional methods
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None